PL345340A1 - Compositions comprising gaba analogs and caffeine - Google Patents

Compositions comprising gaba analogs and caffeine

Info

Publication number
PL345340A1
PL345340A1 PL99345340A PL34534099A PL345340A1 PL 345340 A1 PL345340 A1 PL 345340A1 PL 99345340 A PL99345340 A PL 99345340A PL 34534099 A PL34534099 A PL 34534099A PL 345340 A1 PL345340 A1 PL 345340A1
Authority
PL
Poland
Prior art keywords
caffeine
compositions
gaba analogs
gaba
analogs
Prior art date
Application number
PL99345340A
Other languages
English (en)
Inventor
Leslie Magnus
Catherine A Segal
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PL345340A1 publication Critical patent/PL345340A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL99345340A 1998-07-09 1999-06-18 Compositions comprising gaba analogs and caffeine PL345340A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9213198P 1998-07-09 1998-07-09
PCT/US1999/013670 WO2000002562A1 (en) 1998-07-09 1999-06-18 Compositions comprising gaba analogs and caffeine

Publications (1)

Publication Number Publication Date
PL345340A1 true PL345340A1 (en) 2001-12-17

Family

ID=22231777

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99345340A PL345340A1 (en) 1998-07-09 1999-06-18 Compositions comprising gaba analogs and caffeine

Country Status (13)

Country Link
US (1) US6326374B1 (https=)
EP (1) EP1094817A1 (https=)
JP (1) JP2002520286A (https=)
KR (1) KR20010071777A (https=)
AU (1) AU772156B2 (https=)
BR (1) BR9911917A (https=)
CA (1) CA2332915C (https=)
ID (1) ID28277A (https=)
NO (1) NO20010119L (https=)
NZ (1) NZ508490A (https=)
PL (1) PL345340A1 (https=)
WO (1) WO2000002562A1 (https=)
ZA (1) ZA200007168B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL189872B1 (pl) 1996-07-24 2005-10-31 Warner Lambert Co Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu
US6992109B1 (en) * 1999-04-08 2006-01-31 Segal Catherine A Method for the treatment of incontinence
DK1169060T3 (da) * 1999-04-09 2006-01-16 Euro Celtique Sa Natriumkanalblokkerpræparater og anvendelse deraf
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
DK1423168T3 (da) * 2001-09-03 2006-05-15 Newron Pharm Spa Farmaceutisk præparat omfattende gabapentin eller en analog deraf og et alfa-aminoamid og dets analgetiske anvendelse
ES2292107T3 (es) * 2004-03-12 2008-03-01 Warner-Lambert Company Llc Ligandos de bifosfina simetricos en c1 y su uso en la sintesis asimetrica de pregabalina.
EP1735324B1 (en) * 2004-04-01 2008-08-20 Warner-Lambert Company LLC Preparation of p-chirogenic phospholanes and their use in asymetric synthesis
HRP20100054T1 (hr) * 2004-06-21 2010-05-31 Warner-Lambert Company Llc Dobivanje pregabalina i njemu sličnih spojeva
DK1809271T5 (da) * 2004-09-10 2010-12-06 Newron Pharm Spa Anvendelse af (R)-(halogenbenzyloxy)benzylaminopropanamider som natrium- og/eller calciumkanalselektive modulatorer
EP1963280B1 (en) 2005-12-22 2015-10-28 Newron Pharmaceuticals S.p.A. 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
US7645767B2 (en) * 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
CH699327B1 (de) 2007-02-14 2010-03-15 Oerlikon Heberlein Temco Wattw Vorrichtung zum gleichzeitigen Behandeln von mehreren multifilen Fäden.
WO2009021058A2 (en) 2007-08-06 2009-02-12 Trinity Labortories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
SG157299A1 (en) 2008-05-09 2009-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
US20100190752A1 (en) * 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
WO2011141923A2 (en) 2010-05-14 2011-11-17 Lupin Limited Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin
WO2012059797A1 (en) 2010-11-04 2012-05-10 Lupin Limited Process for synthesis of (s) - pregabalin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656177A (en) * 1982-07-22 1987-04-07 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US5248678A (en) * 1992-06-30 1993-09-28 Fractal Laboratories, Inc. Methods for increasing arousal and alertness and for the amelioration of comatose states
BR9407415A (pt) * 1993-09-07 1996-11-12 Procter & Gamble Composições contendo um sal de aminoácido de agente antiinflamatório não-esteróide de ácido propiônico e caféina
US5443838A (en) * 1993-09-15 1995-08-22 Koenig, Jr.; Steven M. Nutritional supplementation system
UA49011C2 (uk) * 1996-03-14 2002-09-16 Варнер-Ламберт Компані Похідні циклічної амінокислоти, фармацевтична композиція та спосіб лікування
WO1998007447A1 (en) 1996-08-23 1998-02-26 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
WO1998017627A1 (en) * 1996-10-23 1998-04-30 Warner-Lambert Company Substituted gamma aminobutyric acids as pharmaceutical agents
JP3782935B2 (ja) * 1997-09-08 2006-06-07 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 抗癲癇化合物を含有する鎮痛剤組成物およびその使用方法

Also Published As

Publication number Publication date
US6326374B1 (en) 2001-12-04
KR20010071777A (ko) 2001-07-31
AU4691099A (en) 2000-02-01
NO20010119D0 (no) 2001-01-08
BR9911917A (pt) 2001-03-27
CA2332915A1 (en) 2000-01-20
ZA200007168B (en) 2002-03-04
EP1094817A1 (en) 2001-05-02
AU772156B2 (en) 2004-04-08
NZ508490A (en) 2003-08-29
NO20010119L (no) 2001-01-08
WO2000002562A1 (en) 2000-01-20
ID28277A (id) 2001-05-10
JP2002520286A (ja) 2002-07-09
CA2332915C (en) 2006-10-24

Similar Documents

Publication Publication Date Title
HUP0002187A3 (en) Confectionery compositions
HUP9903759A3 (en) Abtimicrobial compositions
GB9804013D0 (en) Formulations
GB9726814D0 (en) Compositions
PL345340A1 (en) Compositions comprising gaba analogs and caffeine
GB9702238D0 (en) Compositions
IL130856A0 (en) Peroxetine compositions
PL338922A1 (en) Oral compositions
GB2335372B (en) Game
GB9815002D0 (en) Formulations
GB9724838D0 (en) Compositions
GB9815001D0 (en) Formulations
GB9705340D0 (en) Compositions
GB9703109D0 (en) Compositions
GB9712981D0 (en) Compositions
GB2336368B (en) Compositions
IL137209A0 (en) Pharmaceutical compositions comprising disulfiram
TW369931U (en) Random-number-selective game set
GB9703375D0 (en) Compositions
GB9708791D0 (en) Compositions
GB9713213D0 (en) Compositions
GB9713214D0 (en) Compositions
GB9713215D0 (en) Compositions
GB9713216D0 (en) Compositions
GB9714273D0 (en) Compositions

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)